Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

NCT03081052 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03081052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03081052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
May 4, 2017
Completion date
September 5, 2021
Enrollment
519 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant surgery, lung transplant surgery